Anti-VTN antibody
Specifications
| Product type: | Primary antibody |
| Antigen: | VTN |
| Immunogen: | Recombinant protein |
| Species immunized: | Mouse |
| Isotype: | IgG2b |
| Applications: | Western Blot (1:450-1:2000); Immunohistochemistry(1:40-1:200); Flow Cytometry (1:40-1:100) |
| Reactivity: | Human |
| Clonality (clone number): | Monoclonal (G11-5E) |
| Form: | Liquid |
| Buffer: | Tris-HCl buffer (pH7.4), 1% BSA, 40% glycerol, 0.05% NaN3. |
| Concentration: | 1mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | Complement S Protein antibody |
| Epibolin antibody | |
| S Protein antibody | |
| S-protein antibody | |
| Serum Spreading Factor antibody | |
| Serum-spreading factor antibody | |
| Somatomedin B antibody | |
| Somatomedin-B antibody | |
| V75 antibody | |
| Vitronectin V10 subunit antibody | |
| Vitronectin V65 subunit antibody | |
| VN antibody | |
| VNT antibody | |
| VTN antibody | |
| VTNC_HUMAN antibody |
Show More
Target information
Vitronectin is a cell adhesion and spreading factor found in serum and tissues. Vitronectin interact with glycosaminoglycans and proteoglycans. Is recognized by certain members of the integrin family and serves as a cell-to-substrate adhesion molecule. Inhibitor of the membrane-damaging effect of the terminal cytolytic complement pathway.
Somatomedin-B is a growth hormone-dependent serum factor with protease-inhibiting activity.
Provider
Erpantech Laboratory
